What Five Years of the CARPE Registry Can Tell Busy Adults About Chronic Hand Eczema

A registry follows care rather than assigning one cream

The German CARPE registry included 1,281 people with chronic hand eczema. At entry, average disease duration was 6.1 years and 22.4% had severe disease on the physician's global assessment. Researchers described improvements in severity, quality of life and treatment satisfaction during continuing dermatological care. However, 793 participants completed two-year follow-up and only 231 completed five-year follow-up. ^[1]

These were descriptive observations, not a randomized test of one treatment. People received different care; some used systemic medicines. Because the later group was much smaller, its outcomes cannot automatically represent everyone initially enrolled. The registry also did not evaluate Dr. Arsy #003 or show that moisturizer alone explains improvement. ^[1]

Track function without turning your week into a laboratory

Our suggested journal starts with one sentence about the activity most affected: cooking, typing, making beds, opening packages or helping a child dress. Add what the skin felt like, what care you used and whether there was an unusual exposure. The goal is a useful account for an appointment, not a self-diagnosis or a score you must improve every day.

A calendar can make patterns easier to describe. Keep workdays and days off visible, and mark medical changes without assuming every change caused the next improvement or flare. Symptoms fluctuate. A good day after a new cream does not prove that the cream was responsible, just as one difficult day does not settle a long-term treatment question.

Consider a review that asks about comfort, daily function and the burden of following the routine. Those are separate issues. If a plan is too difficult to fit around work and family, explain which step is failing in practice so the clinician can help adapt it.

Choosing an eczema moisturizer within continuing care

An eczema moisturizer is a supportive skin-care choice rather than a substitute for a diagnosis. The AAD discusses fragrance-free skin care and moisturizing in its home-care advice. ^[2] For the personal moisture step, Dr. Arsy Moisturizer #003 is a rich, fragrance-free cosmetic cream intended for dry, sensitive and eczema-prone skin, with face, hand and body use according to its label.

A practical comparison includes the ingredient list, how the product feels on your own skin, access and the instructions that accompany prescribed care. Record the actual product name when discussing your routine. A registry describing many forms of medical management cannot be used to promise the same result from a particular jar.

If a moisturizer repeatedly stings or seems to worsen your rash, bring that observation to the clinician rather than layering more products over it. A simple, well-described routine is easier to review than a growing collection of unrecorded changes.

Improvement is a review topic, not a fixed deadline

The five-year findings can be encouraging without becoming a timetable. Some people need several treatment adjustments; others need attention to workplace exposure or a different diagnosis. Continued symptoms do not mean someone has failed at self-care.

Arrange a review when fissures, pain or inflammation keep returning or when daily tasks remain difficult. Ask how progress will be assessed and when the plan should change. The useful message from CARPE is the importance of a longer clinical view, together with honest reporting of how much follow-up evidence is actually available.

Research and guidance

1. Chronic hand eczema in Germany: Five-year CARPE registry data (2019)
2. American Academy of Dermatology: Eczema care at home